MedTrace Logo

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

NCT05922657 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-12-16

No results posted yet for this study

Summary

Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.

Conditions

  • Heavy Menstrual Bleeding
  • Abnormal Uterine Bleeding
  • Menorrhagia

Interventions

DEVICE

Cerene

Real world use of Cerene.

Sponsors & Collaborators

  • Channel Medsystems

    lead INDUSTRY

Principal Investigators

  • Edward Yu, MBA · Executive VP of Regulatory, Clinical, and Medical Affairs

Eligibility

Min Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922657 on ClinicalTrials.gov